TOP TIERMARKET NEWSWIRE
News & sentiment

EIKON THERAPEUTICS I (EIKN) — News & AI sentiment

EIKON THERAPEUTICS I (EIKN) news roundup. 1 story in the past week, 13 over 30 days. Average 30-day sentiment is 53.4/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $1.0M and 0 sales totalling $0 — net buying of $1.0M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 63/100
30d stories
13
avg sentiment 53.4/100
Insider net (90d)
$1.0M
1 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

EIKN news in the last 24 hours, 7 days, 30 days and 90 days

How much EIKN coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowEIKN storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days163/100EIKN headlines →
Last 30 days1353.4/100EIKN headlines →
Last 90 days3053.8/100EIKN headlines →

Latest stories on EIKN

Inhibrx, Eikon rise after insider buying
Seeking Alpha63 · neutralgeneral
4d ago
Sep 3
Sep 3
Aug 26
Aug 26
Aug 22
Aug 19
Aug 19
Aug 18
Aug 16
Aug 16
Aug 14
Aug 14
Aug 13
Aug 13
Aug 13
Aug 13
Aug 11
Aug 11
Aug 10
Aug 3
Aug 3
Jul 27
Jul 27
Eikon Therapeutics: Behind The Rough Debut
Seeking Alpha38 · neutralgeneral
Jul 20
Open EIKN in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →